RCM
AGTC

RA Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

RA Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-236,059
Closed -$3.3M – 40
2016
Q1 		$3.3M Hold
236,059
– – 0.42% 35
2015
Q4 		$4.82M Buy
236,059
+114,959
+95% +$1.77M 0.48% 31
2015
Q3 		$1.59M Buy
+121,100
New +$2.01M 0.23% 41

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

RA Capital Management's AGTC Position: Q2 2016 in Review

RA Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2016, closing a stake of 236,059 shares — an estimated $3.3M sold.

RA Capital Management first reported a position in AGTC in Q3 2015 and held it in 3 quarters. The position peaked at $4.82M in Q4 2015. 94 funds tracked by Wall St. Rank hold AGTC as of Q2 2016.

  • RA Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2016 after selling out during the quarter.
  • RA Capital Management sold 236,059 Applied Genetic Technologies Corporation shares in Q2 2016, an estimated $3.3M.
  • RA Capital Management first reported a position in Applied Genetic Technologies Corporation in Q3 2015 and held it in 3 quarters.
  • RA Capital Management's Applied Genetic Technologies Corporation position peaked at $4.82M in Q4 2015.
  • 94 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2016.

Based on RA Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.